The invention provides the identification and characterization of a diseaseand cancer-associated antigen, KID24. The invention also provides modulatorsof KID24, including a family of monoclonal antibodies that bind to antigenKID24, and methods of diagnosing and treating various human cancers anddiseases associated with KID24.